From Wikipedia, the free encyclopedia
Medication
Velagliflozin
|
|
Trade names | Senvelgo |
---|
License data |
|
---|
Routes of administration |
By mouth |
---|
ATCvet code | |
---|
|
Legal status |
|
---|
|
2-[(4-cyclopropylphenyl)methyl]-4-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]benzonitrile
|
CAS Number | |
---|
PubChem
CID | |
---|
ChemSpider | |
---|
UNII | |
---|
|
Formula | C23H25NO5 |
---|
Molar mass | 395.455 g·mol−1 |
---|
3D model (
JSmol) | |
---|
C1CC1C2=CC=C(C=C2)CC3=C(C=CC(=C3)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)C#N
|
InChI=1S/C23H25NO5/c24-11-17-8-7-16(23-22(28)21(27)20(26)19(12-25)29-23)10-18(17)9-13-1-3-14(4-2-13)15-5-6-15/h1-4,7-8,10,15,19-23,25-28H,5-6,9,12H2/t19-,20-,21+,22-,23+/m1/s1 Key:SENUNDCNOYAWGN-ZQGJOIPISA-N Key:UWKBFNWQMSGEPG-ZHNCTCHCSA-N
|
Velagliflozin, sold under the brand name Senvelgo, is an
antidiabetic medication used for the treatment of cats.
[1]
[2] Velagliflozin is a
sodium-glucose cotransporter 2 (SGLT2) inhibitor.
[3] It is taken
by mouth.
[1]
Medical uses
Velagliflozin is
indicated to improve glycemic control in otherwise healthy cats with diabetes not previously treated with insulin.
[1]
[2]
[3]
References
|
---|
|
---|
fast-acting | |
---|
short-acting | |
---|
long-acting | |
---|
ultra-long-acting | |
---|
inhalable | |
---|
|
|
|
|
---|
SGLT1Tooltip Sodium-glucose transporter 1 | |
---|
SGLT2Tooltip Sodium-glucose transporter 2 | |
---|
SGLT1Tooltip Sodium-glucose transporter 1 &
SGLT2Tooltip Sodium-glucose transporter 2 | |
---|
|